Fumafer



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 63.1%
Foetal Exposure During Pregnancy 10.7%
Maternal Exposure Timing Unspecified 10.7%
Nausea 1.8%
Urinary Tract Infection 1.6%
Breast Cancer 1.3%
Drug Use For Unknown Indication 1.3%
Parenteral Nutrition 1.3%
Prophylaxis 1.3%
Induction Of Anaesthesia 1.0%
Anxiety 0.8%
Maternal Exposure Before Pregnancy 0.8%
Bacterial Infection 0.5%
Calcium Deficiency 0.5%
Depression 0.5%
Device Related Infection 0.5%
Dyslipidaemia 0.5%
Foetal Growth Restriction 0.5%
Hypertension 0.5%
Hyperthermia 0.5%
Premature Baby 16.7%
Foetal Growth Restriction 11.9%
Maternal Exposure Timing Unspecified 9.5%
Skin Exfoliation 9.5%
Neutrophil Count Decreased 4.8%
Pulmonary Embolism 4.8%
Rash Maculo-papular 4.8%
Somnolence 4.8%
Thrombocytopenia 4.8%
Vomiting 4.8%
Bicytopenia 2.4%
Maternal Drugs Affecting Foetus 2.4%
Pregnancy 2.4%
Premature Labour 2.4%
Pulmonary Infarction 2.4%
Rhabdomyolysis 2.4%
Staphylococcal Infection 2.4%
Toxic Skin Eruption 2.4%
Urosepsis 2.4%
Weight Decreased 2.4%
Concomitant
Drug Use For Unknown Indication 33.6%
Product Used For Unknown Indication 18.3%
Hypertension 9.6%
Pain 5.0%
Thrombosis Prophylaxis 4.3%
Iron Deficiency 3.4%
Type 2 Diabetes Mellitus 2.8%
Hypercholesterolaemia 2.5%
Renal Failure Chronic 2.5%
Depression 2.1%
Hiv Infection 2.1%
Anaemia 2.0%
Rheumatoid Arthritis 2.0%
Asthma 1.6%
Atrial Fibrillation 1.6%
Diabetes Mellitus 1.4%
Pulmonary Tuberculosis 1.4%
Cardiac Failure 1.2%
Chronic Lymphocytic Leukaemia 1.2%
Iron Deficiency Anaemia 1.2%
Pregnancy 9.6%
Malaise 8.5%
Renal Failure Acute 8.5%
Sepsis 7.4%
Thrombocytopenia 7.4%
Drug Ineffective 5.3%
Neutropenia 5.3%
Deep Vein Thrombosis 4.3%
General Physical Health Deterioration 4.3%
Oesophageal Pain 4.3%
Paralysis 4.3%
Staphylococcal Infection 4.3%
Ultrasound Antenatal Screen Abnormal 4.3%
International Normalised Ratio Increased 3.2%
Off Label Use 3.2%
Pancytopenia 3.2%
Pharyngolaryngeal Pain 3.2%
Rectal Haemorrhage 3.2%
Respiratory Distress 3.2%
Somnolence 3.2%